# NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients

> **NCT03969303** · — · COMPLETED · sponsor: **Notal Vision Ltd.** · enrollment: 287 (actual)

## Conditions studied

- AMD - Age-Related Macular Degeneration
- Diabetic Macular Edema

## Interventions

- **DEVICE:** Notal Vision Optical Coherence Tomography Device Version 2.5 (NOTAL-OCT V2.5)

## Key facts

- **NCT ID:** NCT03969303
- **Lead sponsor:** Notal Vision Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-20
- **Primary completion:** 2019-07-11
- **Final completion:** 2019-10-04
- **Target enrollment:** 287 (ACTUAL)
- **Last updated:** 2020-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03969303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03969303, "NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03969303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*